Showing results (891-900 of 1,075) with videos related to
Sort By:
Pageof 108
Clinical Pharmacology and Therapeutics|October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary InterventionLarisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.Clinical and Translational Science|August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategiesLarisa H Cavallari, Craig R Lee, Francesco Franchi, et al.JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.Journal of the American College of Cardiology|October 1, 2013
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleedingUdaya S Tantry, Laurent Bonello, Daniel Aradi, et al.Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary InterventionDominick J Angiolillo, Usman Baber, Samantha Sartori, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO RegistryJennifer Rymer, Brooke Alhanti, Steven Kemp, et al.Journal of the American Heart Association|June 14, 2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary InterventionKayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.JAMA|March 17, 2011
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trialMatthew J Price, Peter B Berger, Paul S Teirstein, et al.European Journal of Preventive Cardiology|July 23, 2026
Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary InterventionFrancesca Maria Di Muro, Samantha Sartori, Dominick J Angiolillo, et al.Pageof 108